课题基金 / 基金详情

HETEROGENEITY AND MALIGNANT PROGRESSION OF HUMAN BREAST

HETEROGENEITY AND MALIGNANT PROGRESSION OF HUMAN BREAST
人类乳腺的异质性和恶性进展
批准号:
3176982
负责人:
HELENE S SMITH
金额:
$17.87万
依托单位国家:
美国
项目类别:
财政年份:
1985
资助国家:
美国
项目状态:
已结题
起止时间:
1985-07-01 至 1988-06-30

项目摘要

项目成果

HELENE S SMITH的其他基金

相似基金

相关文献

中文摘要
翻译
人类乳腺癌异质性的本质与恶性进展 癌症将通过研究分离自 短期培养前后的乳腺癌。 亚群 将根据侵袭性,倍性水平, 分化标志物的表达,或细胞间 粘性。 这些从癌细胞中分离出来的亚群将是 培养,进一步表征,并与从细胞培养的细胞进行比较。 恶性进展的极端(即正常组织和转移性组织) 渗出液)。 将使用剥脱羊膜试验测量侵袭性; 通过流式细胞术,显微分光光度法, 和细胞核学。 为了测量分化,我们将利用单克隆 抗乳脂球抗原、肌上皮抗原、 抗α-乳白蛋白多价抗体和脂质组织化学染色 颗粒。 要检查的其他属性,包括各种 细胞外基质和基因扩增能力。 一 有趣的结果是,我们预计,我们将有特点, 原发癌中的各种亚群,并将其与 非恶性乳腺上皮细胞表达的特性, 与恶性肿瘤相关的文化。 通过这种方式,我们将尝试 确定这些表型对乳腺癌的意义, 以确定细胞获取相关属性的顺序 恶性肿瘤 例如,如果肿瘤通过首先获得 属性“a”,然后是“B”,最后是“c”,人们会期望 肿瘤获得了属性“a”,而只有一些细胞会有“a”, “B”和更少的将表达所有三个属性。 我们建议确定 该序列用于许多不同组织学的乳腺癌, 类型,以了解乳腺癌中异质性表现的程度 癌
英文摘要
The nature of heterogeneity and malignant progression of human breast cancers will be evaluated by studying various subpopulations isolated from mammary carcinomas before and after short term culture. Subpopulations will be selected initially on the basis of invasiveness, ploidy level, expression of differentiation markers, or degree of intercellular adhesiveness. These isolated subpopulations from the carcinomas will be cultured, further characterized, and compared to cells cultured from the extremes of malignant progression, (i.e. normal tissues and metastatic effusions). Invasiveness will be measured using a denuded amnion assay; ploidy levels will be determined by flow cytometry, microspectrophotometry, and karyology. For measuring differentiation, we will utilize monoclonal antibodies to milk fat globule antigen, a myoepithelial antigen, a polyvalent antibody to alpha-lactalbumin and histochemical stain for lipid granules. Other properties to be examined to include behavior on various extracellular matrices, and capacity for gene amplification. One interesting outcome that we anticipate is that we will have characterized various subpopulations within the primary carcinoma and compared them with nonmalignant mammary epithelial cells for expression of properties in culture associated with malignancy. In this way, we will attempt to determine the significance of these phenotypes for breast cancer and also to determine the sequence(s) by which cells acquire properties associated with malignancy. For example, if a tumor progresses by first acquiring property "a", then "b", and finally "c", one would expect most cells in the tumor to have gained property "a" while only some cells would have "a" and "b" and fewer would express all three properties. We propose to determine this sequence for a number of breast carcinomas of different histologic types in order to understand the extent of heterogeneity manifest in breast cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MOLECULAR MARKERS FOR HIGH RISK OF BREAST CANCER
MOLECULAR MARKERS FOR HIGH RISK OF BREAST CANCER
MOLECULAR MARKERS FOR HIGH RISK OF BREAST CANCER
GENETIC MARKERS OF AGGRESSIVE BEHAVIOR IN BREAST CANCER
海外基金